Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer According to the BASQ Classification

NCT03577132 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03577132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03577132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer According to the BASQ Classification
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2018
Completion date
May 31, 2022
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma